Memorial Sloan Kettering Cancer Center· @MSKCancerCenter · X·· 2026-04-21Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
Join
@TheVinodLab
, an MSK physician-scientist and Director of The Olayan Center for Cancer Vaccines, for a Major Symposium sharing new research about “Personalized neoantigen vaccines for #pancreaticcancer” TODAY at #AACR26.
: Monday, April 20 at 1:35pm PDT
Learn more:
Heat 29 · 20 likes · 2 replies · 7 reposts
Source: Memorial Sloan Kettering Cancer Center · x.com